News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

All news

Show

From To
New laboratory tests to enhance TB diagnosis: Microscopy, LAM and Xpert MTB/RIF used as a drug resistance test

This edition of HATIP is kindly supported by the Lilly MDR-TB Partnership. This article forms the third in a three-part series on the implications of

Published
25 May 2012
From
HIV & AIDS treatment in practice
New and experimental treatments
Gilead Files European Marketing Application for Boosting Agent Cobicistat

Gilead Sciences, Inc. announced today that the Marketing Authorisation Application (MAA) for cobicistat, submitted on April 26, 2012, has been validated by the European Medicines Agency (EMA).

Published
25 May 2012
From
Gilead press release
Drug-resistant TB
MDR-TB and the BRICS

At the 65th World Health Assembly, UNITAID held a technical briefing to propose a new paradigm for middle-income countries to drive multidrug-resistant tuberculosis (MDR-TB) markets for greater public health good

Published
25 May 2012
From
UNITAID
Pharmaceutical industry
Mylan launches HIV-drug nevirapine in US

Mylan Inc's subsidiary Mylan Pharmaceuticals Inc. has received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Nevirapine tablets USP, 200 mg. This product is the generic version of Boehringer Ingelheim's Viramune and is indicated for combination antiretroviral (ARV) treatment of HIV-1 infection.

Published
25 May 2012
From
pharmabiz.com
Transmission and prevention
Beginning to End the AIDS Epidemic: What’s the Research Agenda?

Looking back over three decades of AIDS, it’s hard to point to a better investment than research. Over the past three years, a string of HIV prevention research breakthroughs has put the ambitious goal of even talking about an end of AIDS within sight for the first time. With more strategic use of the tools we have today, we can bend the curve of new infections.

Published
25 May 2012
From
Science Speaks
History of HIV and AIDS
Monkey meat that could be behind the next HIV

The human immunodeficiency virus (HIV) is now widely believed to have originated in chimps. Apes are known to host other potentially deadly viruses, such as ebola, anthrax, yellow fever and other potential viruses yet to be discovered. Deep in Cameroon's rainforests, poachers are killing primates for food. Evan Williams reports from Yokadouma on a practice that could create a pandemic

Published
25 May 2012
From
The Independent
TB transmission
KENYA: Curbing the spread of TB in infected households

Good hygiene practices are an important component of TB infection control and prevention, but maintaining them is not easy in an informal settlement, where houses are crammed together and sanitation facilities hard to come by.

Published
25 May 2012
From
IRIN Plus News
Prevention of mother-to-child transmission
Ministers Meet To Discuss Global Plan To Eliminate New HIV Infections Among Children

UNAIDS and PEPFAR recently brought together the ministers of health and representatives of the 22 countries with the most new HIV cases among children to discuss progress on the Global Plan towards the Elimination of New HIV Infections among Children by 2015 and Keeping Their Mothers Alive agreed to at the 2011 U.N. High-Level Meeting on AIDS, according to a UNAIDS press release.

Published
25 May 2012
From
Kaiser Daily Global Health Policy Report
Cardiovascular disease
Starting HIV treatment with a CD4 cell count below 350 associated with a key marker of cardiovascular risk

Starting HIV treatment with a CD4 cell count below 350 cells/mm3 may increase the long-term risk of cardiovascular disease, US research published in AIDS suggests. Investigators found

Published
25 May 2012
By
Michael Carter
Mental and emotional health
‘Gay cure’ therapist loses appeal against the British Association of Counselling and Psychotherapy

Lesley Pilkington, a psychotherapist who was found guilty of ‘professional malpractice’ for using the techniques of ‘conversion therapy’ (a bogus form of treatment which is supposed to make gay people become straight) has lost her appeal against the British Association for Counselling and Psychotherapy (BACP). Mrs Pilkington was found guilty of malpractice last year after trying to convert a gay client to heterosexuality, with the BACP describing her practice as ‘negligent’, ‘dogmatic’ and ‘unprofessional’.

Published
24 May 2012
From
British Humanist Association
← First12345...1186Next →

Filter by country